MARKETS / COMPANIES / ECONOMYRSS edition ↗
Listing Beacon
Market News

I-T dept moves appellate tribunal against Rs 32.66-cr tax relief to Dr Lal

Benchmarks Nifty22,622.70-99.25FEATURED FUNDS★★★★★UTI Aggressive Hybrid Fund Regular Plan-Growth5Y Return8.71 % Invest NowFEATURED FUNDS★★★★★Motilal Oswal Midcap Fund Direct-Growth5Y Return19.29 % Invest NowEnter search…

I-T dept moves appellate tribunal against Rs 32.66-cr tax relief to Dr Lal
Benchmarks Nifty22,622.70-99.25FEATURED FUNDS★★★★★UTI Aggressive Hybrid Fund Regular Plan-Growth5Y Return8.71 % Invest NowFEATURED FUNDS★★★★★Motilal Oswal Midcap Fund Direct-Growth5Y Return19.29 % Invest NowEnter search text:
    The Economic Times daily newspaper is available online now. Read Today's Paper I-T dept moves appellate tribunal against Rs 32.66-cr tax relief to Dr Lal PathLabsPTILast Updated: Oct 09, 2026, 12:29:00 AM ISTSynopsis

    Dr Lal PathLabs, in a regulatory filing, said that it received an intimation on Wednesday regarding an appeal filed by the I-T Department before the Income Tax Appellate Tribunal (ITAT), New Delhi.

    Listen to this article in summarized format

    Loading...×New Delhi: The Income Tax Department has moved to the appellate tribunal, ITAT, challenging the tax relief granted to Dr Lal PathLabs for an expense of Rs 32.66 cr, the diagnostic services provider said on Thursday.

    Dr Lal PathLabs, in a regulatory filing, said that it received an intimation on Wednesday regarding an appeal filed by the I-T Department before the Income Tax Appellate Tribunal (ITAT), New Delhi.

    The department has challenged an order passed by the Commissioner of Income Tax (Appeals) granting relief to the company for Assessment Year 2022-23 under Section 250 of the Income Tax Act, 1961, the filing said.

    Also read | Dr Reddy’s Laboratories receives two observations for Andhra Pradesh facility

    The order provided relief to the company against the disallowance of ESOP expenses amounting to Rs 32,66,18,927.

    Live Events


        Dr Lal PathLabs said it "does not reasonably expect the outcome of the appeal to have any material impact" on the company.
        Add as a Reliable and Trusted News Source Add Now!
        (You can now subscribe to our Economic Times WhatsApp channel)
        Read More News ondr lal pathlabsDr Lal PathLabsIncome Tax DepartmentDr Lal PathLabs tax caseDr Lal PathLabs tax reliefDr Lal PathLabs tax notice

        (Catch all the Business News, Breaking News and Latest News Updates on The Economic Times.)

        ...moreless
        (You can now subscribe to our Economic Times WhatsApp channel)
        Read More News ondr lal pathlabsDr Lal PathLabsIncome Tax DepartmentDr Lal PathLabs tax caseDr Lal PathLabs tax reliefDr Lal PathLabs tax notice

        (Catch all the Business News, Breaking News and Latest News Updates on The Economic Times.)

        ...moreless

        Stories you might be interested in

          Source: Economic Times — Healthcare/Biotech ↗

          Figures reflect the source report and its stated period. This article is for information and is not investment advice.